Irene E van der Horst-Bruinsma
Overview
Explore the profile of Irene E van der Horst-Bruinsma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
3942
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koc G, Looijen A, van der Horst-Bruinsma I, de Jong P
J Rheumatol
. 2025 Mar;
PMID: 40042004
Objective: The disease course and burden of rheumatoid arthritis (RA) may differ between female and male individuals, but existing data on these differences are limited and often contradictory. Therefore, we...
2.
Vegt D, Popa-Diaconu D, Mulder M, van Leuven S, van der Horst-Bruinsma I
Curr Rheumatol Rep
. 2024 Dec;
27(1):6.
PMID: 39641871
Purpose Of The Review: This narrative review aims to discuss the most recent studies regarding the risk of cardiovascular disease (CVD) in women with psoriasis, psoriatic arthritis (PsA) and spondyloarthritis...
3.
Hellamand P, van de Sande M, Nurmohamed M, van Vollenhoven R, Hollick R, Rotariu O, et al.
Rheumatology (Oxford)
. 2024 Jul;
PMID: 39041780
Objectives: To investigate sex differences in patient-reported outcome measures (PROMs) among axSpA patients initiating their first TNFi and identify factors contributing to these disparities over the follow-up. Methods: Data were...
4.
Harlianto N, Ezzafzafi S, Foppen W, Kuperus J, van der Horst-Bruinsma I, de Jong P, et al.
N Am Spine Soc J
. 2024 Feb;
17:100312.
PMID: 38370336
Background: Subjects with ankylosing spinal disorders, including diffuse idiopathic skeletal hyperostosis (DISH) and ankylosing spondylitis (AS) are more prone to vertebral fractures and frequently present with neurological deficit compared to...
5.
Hellamand P, van de Sande M, Ornbjerg L, Klausch T, Eklund K, Relas H, et al.
Arthritis Rheumatol
. 2023 Nov;
76(4):587-598.
PMID: 37975166
Objective: Women with psoriatic arthritis (PsA) may have reduced tumor necrosis factor inhibitor (TNFi) effectiveness compared to men. We examined sex differences in treatment response and retention rates during 24...
6.
Konsta M, van der Horst-Bruinsma I
J Rheumatol
. 2023 Oct;
PMID: 37839821
We thank Dr. Slouma et al for their earnest interest in our recent article, which examined the prevalence and radiographic progression of hip involvement in patients with ankylosing spondylitis (AS)...
7.
van Kuijk A, Nurmohamed M, Siebert S, Bergmans P, De Vlam K, Gremese E, et al.
Rheumatology (Oxford)
. 2023 Feb;
62(10):3382-3390.
PMID: 36810788
Objective: Investigate effects of gender on disease characteristics and treatment impact in patients with PsA. Methods: PsABio is a non-interventional European study in patients with PsA starting a biological DMARD...
8.
de Jongh J, Verweij N, Yaqub M, van Denderen C, van der Horst-Bruinsma I, Bot J, et al.
Eur J Nucl Med Mol Imaging
. 2022 Dec;
50(5):1351-1359.
PMID: 36508028
Purpose: To relate [F]fluoride uptake on PET with abnormalities on magnetic resonance imaging (MRI) and conventional radiography (CR) in ankylosing spondylitis (AS) patients. Methods: Ten clinically active AS patients (female...
9.
de Jongh J, Hemke R, Zwezerijnen G, Yaqub M, van der Horst-Bruinsma I, van de Sande M, et al.
Eur J Nucl Med Mol Imaging
. 2022 Nov;
50(3):756-764.
PMID: 36370181
Purpose: As bone formation is associated with psoriatic arthritis (PsA), positron emission tomography (PET) using a F-Fluoride tracer may enable sensitive detection of disease activity. Our primary aim was to...
10.
Konsta M, Nurmohamed M, Iliopoulos A, Sfikakis P, van Denderen J, Visman I, et al.
J Rheumatol
. 2022 Nov;
50(3):342-350.
PMID: 36319019
Objective: To examine the prevalence of hip involvement between sexes in patients with ankylosing spondylitis (AS) treated with tumor necrosis factor inhibitors (TNFi) and to estimate the effect of TNFi...